LEM Domain Containing 1 Acts as a Novel Oncogene and Therapeutic Target for Triple-Negative Breast Cancer

SIMPLE SUMMARY: Since TNBC shows the worst prognosis and limited treatment options, exploring novel molecular targets is urgently needed for effective treatment of TNBC. In this study, we demonstrated that LEMD1 is highly expressed in TNBC and contributes to poor prognosis of TNBC patients. LEMD1 si...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiangling, Jiang, Shilong, Jiang, Ting, Sun, Xinyuan, Guan, Yidi, Fan, Songqing, Cheng, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251810/
https://www.ncbi.nlm.nih.gov/pubmed/37296887
http://dx.doi.org/10.3390/cancers15112924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251810/
https://www.ncbi.nlm.nih.gov/pubmed/37296887
http://dx.doi.org/10.3390/cancers15112924

Ejemplares similares